SCHEMBL5258684

SCHEMBL5258684

CNC1CCN(c2ccc(Oc3ccccc3)cc2)CC1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LTA4H P09960 2/20 0.55
DPP4 P27487 2/20 0.48
HRH3 Q9Y5N1 2/20 0.45
MCHR1 Q99705 1/20 0.43
MAPT P10636 3/20 0.43
HTT P42858 3/20 0.43
KDM4E B2RXH2 1/20 0.43
NPC1 O15118 1/20 0.43
GALR3 O60755 1/20 0.43
ALDH1A1 P00352 1/20 0.43
NR2F2 P24468 1/20 0.43
SMN1; SMN2 Q16637 1/20 0.43
LMNA P02545 1/20 0.42
FFAR1 O14842 1/20 0.41
ME3 Q16798 1/20 0.41
EPHX2 P34913 1/20 0.41
USP30 Q70CQ3 2/20 0.40
RXFP1 Q9HBX9 1/20 0.40
CRHBP P24387 1/20 0.40
CRHR2 Q13324 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7049802 0.85 L3MBTL1 (0.52) MCHR1KDM4EALDH1A1SMN1; SMN2LMNA
SCHEMBL786000 0.82 HTR3E (0.54) HRH3MAPTNPC1ALDH1A1SMN1; SMN2
SCHEMBL5214643 0.82 MCHR1 (0.59) HRH3MCHR1ALDH1A1ME3
SCHEMBL2883836 0.81 DRD2 (0.53) LTA4HHRH3MAPTHTTKDM4E
SCHEMBL1749032 0.80 HRH3 (0.65) HRH3MCHR1MAPTHTTKDM4E
SCHEMBL1748880 0.80 HRH3 (0.65) HRH3MCHR1MAPTHTTKDM4E
SCHEMBL1749597 0.80 HRH3 (0.65) HRH3MCHR1MAPTHTTKDM4E
SCHEMBL3891049 0.79 LTA4H (0.60) LTA4HDPP4HRH3MAPTHTT
SCHEMBL13234950 0.79 LTA4H (0.60) LTA4HDPP4HRH3MAPTHTT
SCHEMBL13202835 0.78 LTA4H (0.61) LTA4H

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1228367-B1 AMINOPHENOXYACETAMIDE DERIVATIVES AND PHARMACEUTICAL COMPOSITION CONTAINING THEREOF ASUBIO PHARMA CO LTD (JP) 2007-09-26 EP disclosed
US-20060178401-A1 Aminophenoxyacetamide derivatives and pharmaceutical composition containing thereof DAIICHI ASUBIO PHARMA CO., LTD. 2006-08-10 US disclosed
CN-1264821-C Aminophenoxyacetamide derivatives and pharmaceutical composition containing thereof SUNTORY LTD (JP) 2006-07-19 CN disclosed
US-7067533-B2 Aminophenoxyacetamide derivatives and pharmaceutical composition containing thereof DAIICHI ASUBIO PHARMA CO., LTD. (JP) 2006-06-27 US disclosed
CN-1449493-A Aminophenoxyacetamide derivatives and pharmaceutical compositions containing them SUNTORY LTD (JP) 2003-10-15 CN disclosed
US-20030139447-A1 Aminophenoxyacetamide derivatives and pharmaceutical composition containing thereof ASUBIO PHARMA CO., LTD. (JP) 2003-07-24 US disclosed
EP-1228367-A2 AMINOPHENOXYACETAMIDE DERIVATIVES AND PHARMACEUTICAL COMPOSITION CONTAINING THEREOF SUNTORY LIMITED (JP) 2002-08-07 EP disclosed
WO-2001079170-A2 AMINOPHENOXYACETAMIDE DERIVATIVES AND PHARMACEUTICAL COMPOSITION CONTAINING THEREOF SUNTORY LIMITED (JP) 2001-10-25 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030139447-A1 Aminophenoxyacetamide derivatives and pharmaceutical composition containing thereof SCN10A, CAMK2A, CAMK2B LTA4H 4260/4885DPP4 3263/4885HRH3 2569/4885
US-20060178401-A1 Aminophenoxyacetamide derivatives and pharmaceutical composition containing thereof NR0B1, NR0B2, NR4A1 LTA4H 1554/4885DPP4 2604/4885HRH3 209/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.